← FDA Drug Approvals (Drugs@FDA)

NALMEFENE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PURDUE PHARMA LP · Approved 2022-02-08

Drug application

FDA Application #

ANDA212955

Application type

Abbreviated New Drug Application (Generic)

Brand name

NALMEFENE HYDROCHLORIDE

Generic name

NALMEFENE HYDROCHLORIDE

Active ingredients

NALMEFENE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

PURDUE PHARMA LP

Manufacturer

Knoa Pharma LLC

First approval

2022-02-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown